Your browser is no longer supported. Please, upgrade your browser.
AGN Allergan plc daily Stock Chart
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-15.37 Insider Own0.10% Shs Outstand332.09M Perf Week-3.26%
Market Cap46.60B Forward P/E8.05 EPS next Y17.42 Insider Trans0.84% Shs Float331.74M Perf Month-8.69%
Income-5157.10M PEG- EPS next Q3.54 Inst Own89.00% Short Float1.39% Perf Quarter-10.38%
Sales15.79B P/S2.95 EPS this Y24.90% Inst Trans-0.10% Short Ratio1.73 Perf Half Y-25.36%
Book/sh194.25 P/B0.72 EPS next Y6.37% ROA-4.80% Target Price183.94 Perf Year-15.26%
Cash/sh5.74 P/C24.43 EPS next 5Y4.02% ROE-7.40% 52W Range125.84 - 197.00 Perf YTD4.98%
Dividend2.96 P/FCF10.74 EPS past 5Y-36.00% ROI-4.80% 52W High-28.78% Beta1.34
Dividend %2.11% Quick Ratio1.00 Sales past 5Y43.40% Gross Margin86.10% 52W Low11.50% ATR3.40
Employees16900 Current Ratio1.10 Sales Q/Q-5.70% Oper. Margin-38.30% RSI (14)38.20 Volatility2.95% 2.14%
OptionableYes Debt/Eq0.37 EPS Q/Q-769.60% Profit Margin-32.60% Rel Volume0.78 Prev Close140.03
ShortableYes LT Debt/Eq0.35 EarningsApr 30 BMO Payout- Avg Volume2.68M Price140.31
Recom2.10 SMA20-4.57% SMA50-2.32% SMA200-14.04% Volume2,101,371 Change0.20%
Apr-15-19Initiated Jefferies Hold
Mar-20-19Initiated SunTrust Buy $178
Jan-31-19Downgrade Credit Suisse Outperform → Neutral
Jan-30-19Downgrade RBC Capital Mkts Outperform → Sector Perform
Jan-30-19Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-09-18Resumed Guggenheim Buy
Apr-24-18Resumed Citigroup Buy $200
Apr-23-18Resumed Evercore ISI Outperform
Apr-17-18Initiated Stifel Hold $192
Feb-23-18Initiated SunTrust Buy $200
Feb-07-18Reiterated Leerink Partners Outperform $237 → $242
Dec-07-17Downgrade Argus Buy → Hold
Nov-29-17Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-27-17Resumed Leerink Partners Outperform $237
Nov-02-17Reiterated RBC Capital Mkts Outperform $250 → $221
Oct-19-17Reiterated RBC Capital Mkts Outperform $277 → $250
Oct-17-17Reiterated UBS Buy $275 → $255
Oct-02-17Reiterated Barclays Equal Weight
Sep-25-17Reiterated RBC Capital Mkts Outperform $285 → $277
Sep-20-17Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-18-19 01:51PM  Jerome Dodson Goes 2 for 2 in 1st Quarter
01:43PM  Here's What We Think About Allergan plc's (NYSE:AGN) CEO Pay Simply Wall St.
10:46AM  50 Top Stocks That Billionaires Love Kiplinger
Apr-17-19 11:03AM  Gilead Collaborates With Insitro to Develop NASH Therapies Zacks
Apr-16-19 11:41AM  Allergan Falls as Supreme Court Dismisses Restasis Litigation Zacks
Apr-15-19 04:33PM  Could This Backing Help Allergan's CEO Retain His Chairman Role? Investor's Business Daily
01:59PM  Proxy firms back Allergan in fight against Appaloosa Reuters
11:00AM  New Study Showcases Economic and Community Impact of Allergan's Operations in Ohio PR Newswire
09:54AM  U.S. Supreme Court rejects Allergan bid to use tribe to shield drug patents Reuters
09:46AM  U.S. Supreme Court rejects Allergan bid to use tribe to shield drug patents Reuters
08:02AM  Proxy firms Glass Lewis and ISS back Allergan in fight against Appaloosa Reuters
07:29AM  Proxy firms Glass Lewis, ISS back Allergan in fight against Appaloosa Reuters
07:00AM  Leading Proxy Advisory Firms ISS and Glass Lewis Support ALL of Allergan Board's Voting Recommendations PR Newswire
Apr-14-19 10:31AM  Heres one way to tell if a company is overpaying its CEO MarketWatch
Apr-10-19 10:46AM  Alkermes Reports Positive Data From Schizophrenia Study Zacks
08:00AM  Allergan Earns 2019 ENERGY STAR® Partner of the Year - Sustained Excellence Award for the Sixth Consecutive Year PR Newswire
Apr-09-19 09:55PM  These 3 Value Stocks Are Absurdly Cheap Right Now Motley Fool
02:18PM  Wynn ends A$10 billion acquisition talks with Australia's Crown Resorts Reuters
07:30AM  Allergan to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast PR Newswire
Apr-08-19 06:05PM  Allergan 360° Aesthetics Report Reveals Evolving Beauty Perceptions And Diverse Priorities Around The World PR Newswire
07:30AM  Allergan 360° Aesthetics Report Reveals Evolving Beauty Perceptions And Diverse Priorities Around The World PR Newswire
Apr-05-19 10:34AM  Will Ironwood Suffer From Dependence on Linzess' Progress? Zacks
10:20AM  Pharma Stock Roundup: NVS Inks Immunology Deal, PFE, TEVA Get Drug Approvals in EU Zacks
Apr-04-19 05:46PM  Maker of Botox alternative turns toxin on crippling muscle disorder American City Business Journals
04:40PM  Health Canada plans to suspend Allergan's breast implant license Reuters
04:35PM  Health Canada plans to suspend Allergan's breast implant license Reuters
03:39PM  Editas (EDIT) Inks Cross Licensing Agreement with BlueRock Zacks
01:57PM  Health Canada plans to suspend Allergan's breast implant license Reuters
Apr-03-19 10:00AM  Allergan's AMD Drug Lowers Inflammation in Phase III Study Zacks
Apr-02-19 10:10AM  Will Allergan (AGN) Beat Estimates Again in Its Next Earnings Report? Zacks
07:00AM  Allergan and Molecular Partners Announce Topline Safety Results from MAPLE study of Abicipar pegol PR Newswire
Apr-01-19 04:57PM  Novartis (NVS) to Acquire Subsidiary of IFM Therapeutics Zacks
04:00PM  Spero Gets Fast Track Designation for SPR994, Shares Improve Zacks
12:38PM  Drug companies that benefit from the war on opioid addiction Yahoo Finance
Mar-29-19 03:11PM  7 Weak Blue-Chip Stocks to Trim Immediately InvestorPlace
Mar-28-19 07:14PM  New York sues billionaire family behind maker of OxyContin Associated Press
Mar-27-19 07:55PM  Here is What Hedge Funds Really Think About Allergan plc (AGN) Insider Monkey
Mar-26-19 09:42AM  Company News For Mar 26, 2019 Zacks
09:00AM  Allergan Acquires Envy Medical, Inc., Adding Skin Resurfacing Dermalinfusion System to Best-in-Class Medical Aesthetics Portfolio PR Newswire
Mar-25-19 09:30PM  US experts: Too soon to pull breast implants tied to cancer Associated Press
05:04PM  Hedge fund Appaloosa unimpressed by Allergan board promises Reuters
03:44PM  Botox Maker's Changes Need to Be More Than Cosmetic Bloomberg
10:56AM  Allergan Stock Is Falling Because Its Facing Off With an Activist Investor
08:02AM  Hedge fund Appaloosa unimpressed by Allergan board promises Reuters
Mar-22-19 08:31PM  Allergan promises independent board chair in next leadership change Reuters
06:19PM  Allergan promises independent board chair in next leadership change Reuters
05:44PM  Allergan plans independent board chairman Reuters
Mar-21-19 09:00AM  CoolSculpting® and Sonja Morgan Talk Bikini Denial Just In Time For Summer PR Newswire
08:19AM  Zacks Market Edge Highlights: Edwards Lifesciences, Exact Sciences, Aimmune Therapeutics, Allergan and Evolus Zacks
Mar-20-19 03:25PM  NASH, Allergies and Beauty Stocks: Invest or Not? Zacks
02:55PM  Allergan Stock Wont Benefit From a Breakup, Analyst Says
01:09PM  10 Stocks on the Rise Heading Into the Second Quarter InvestorPlace
11:10AM  Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan Zacks
10:00AM  CoolSculpting® and Sonja Morgan Partner to Talk Bikini Denial PR Newswire
08:00AM  Here are the biggest analyst calls of the day: Lyft, Monster, FedEx, Rockwell Automation & more CNBC
Mar-19-19 11:51AM  Allergan's Anti-Infective Gets FDA Nod for Pediatric Patients Zacks
Mar-18-19 01:36PM  Big Pharma Earnings Might Not Be as Good as They Look
09:54AM  Group with consumer-friendly vibe pushes drugmakers' message Associated Press
09:01AM  The Zacks Analyst Blog Highlights: Pfizer, Roche, Merck, Allergan and J&J Zacks
07:30AM  Allergan Announces FDA Approval of AVYCAZ® (ceftazidime and avibactam) for Pediatric Patients PR Newswire
Mar-15-19 10:31AM  Pharma Stock Roundup: Regulatory Updates From MRK, PFE, J&J, AGN & Others Zacks
Mar-14-19 03:12PM  5 Undervalued Stocks to Invest In InvestorPlace
07:30AM  Allergan to Present New Data - "Extended Duration of Intraocular Pressure (IOP) Control with Intracameral Bimatoprost Sustained-Release (SR) Implant" -- Highlighting Clinical Advances at the American Glaucoma Society Annual Meeting PR Newswire
Mar-12-19 10:20AM  Allergan Announces FDA Acceptance of Migraine Candidate NDA Zacks
Mar-11-19 03:41PM  Allergan Stock Could Get a Boost From a Company Breakup, Analyst Says
09:40AM  Is Allergan (AGN) a Worthy Pick ForValue Investors Now? Zacks
07:30AM  Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine PR Newswire
Mar-10-19 09:19AM  Did Changing Sentiment Drive Allergans (NYSE:AGN) Share Price Down A Worrying 51%? Simply Wall St.
Mar-09-19 10:03AM  [$$] Why Allergan Shareholders Love Bad News The Wall Street Journal
Mar-08-19 02:22PM  Allergan Stocks Comeback Has Stalled, but CEO Brent Saunders Is Buying
Mar-07-19 04:53PM  Why News From J&J, Allergan Could Be A Boon For This Biotech Stock Investor's Business Daily
04:20PM  Could Kroger Lose the Grocery Wars Over This Challenge?
01:20PM  Activists Aim to Eliminate Dual Role for Allergan CEO Saunders
12:17PM  Allergan Stock Is Up, but Investors Are Worried About Its Drug Pipeline
11:37AM  US STOCKS-Dovish ECB stance pushes Wall St to fourth day of losses Reuters
11:28AM  Appaloosa steps up pressure on Allergan after failed drug trials Reuters
11:06AM  Appaloosa steps up pressure on Allergan after failed depression drug trials Reuters
10:54AM  Allergan's Depression Drug Letdown Largely Expected: Analysts Focus On Remainder Of Pipeline Benzinga
10:20AM  Allergan Rises After FDA Accepts License Applications for Botox Supplements
08:48AM  Allergan's Depression Candidate Fails in Studies, Stock Down Zacks
08:00AM  FDA Accepts Supplemental Biologics License Applications (sBLAs) for BOTOX® (onabotulinumtoxinA) for Pediatric Patients with Upper and Lower Limb Spasticity PR Newswire
07:47AM  Stocks making the biggest moves premarket: Allergan, General Electric, Qualcomm & more CNBC
03:29AM  Stocks - Kroger Plunges in Premarket, American Eagle Outfitters, Allergan Drop
Mar-06-19 07:42PM  Today's After-Hours News: Allergan and American Eagle Are Trading Lower Motley Fool
05:02PM  Stocks making the biggest moves after hours: American Eagle, Allergan and more CNBC
04:28PM  Allergan stock falls after depression study fails MarketWatch
04:17PM  Allergan Announces Phase 3 Results for Rapastinel as an Adjunctive Treatment of Major Depressive Disorder (MDD) PR Newswire
12:54PM  Stocks Moving After Hours: Barnes & Noble, Rosetta Stone, American Eagle, GE
08:50AM  J&J's (JNJ) Nasal Spray Spravato Gets FDA Nod for Depression Zacks
Mar-04-19 10:12AM  Okta (OKTA) to Report Q4 Earnings: How Are Things Shaping Up? Zacks
07:30AM  Allergan to Present at The Cowen and Company 39th Annual Health Care Conference PR Newswire
Mar-01-19 07:30AM  Allergan Presents Data From Seven Abstracts At The 2019 American Academy of Dermatology (AAD) in Washington D.C. PR Newswire
Feb-28-19 11:22PM  Editas Medicine Inc (EDIT) Q4 2018 Earnings Conference Call Transcript Motley Fool
03:02PM  Allergan shareholder Chevedden backs Appaloosa's proposal to split CEO-chairman role Reuters
02:18PM  Allergan shareholder Chevedden backs Appaloosa's proposal to split CEO-chairman role Reuters
Feb-27-19 07:19AM  Editas (EDIT) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-21-19 09:47AM  2 Frustrating Flops, Plus Welcome to the Wrinkle Wars Motley Fool
07:20AM  Research Report Identifies SS&C Technologies, Allergan plc, CorMedix, The Allstate, Vedanta, and Lexicon Pharmaceuticals with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Feb-20-19 09:08AM  Allergan Responds to Investor's Call for CEO/Chair Role Split Zacks
Feb-19-19 04:05PM  Allergan should explore selling itself: Appaloosa's Tepper Reuters
Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company operates in three segments: US Specialized Therapeutics, US General Medicine, and International. It offers a portfolio of products in various therapeutic areas, including medical aesthetics and dermatology, eye care, neuroscience, urology, gastrointestinal, women's health, and anti-infective therapeutic products. The company also offers breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. In addition, it develops medical and cosmetic treatments; therapies for non-alcoholic steatohepatitis and other liver diseases; inhibitor for the treatment of psoriasis and other autoimmune disorders; atopic dermatitis drug candidate; peri-ocular rings for extended drug delivery and reducing elevated intraocular pressure in glaucoma patients; and treatments for neurodegenerative disorders, including Alzheimer's disease. Further, the company develops RST-001, a novel gene therapy for the treatment of retinitis pigmentosa; small molecule therapeutics for inflammatory and fibrotic diseases; topical medicines for fat reduction; and delivery system and botulinum toxin-based prescription products. It has collaboration, option, and license agreement with Lyndra, Inc.; and strategic alliance and option agreement with Editas Medicine, Inc. Allergan plc also has licensing agreements with Assembly Biosciences, Inc.; MedImmune; and Heptares Therapeutics, Ltd. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAUNDERS BRENT LChairman, President and CEOMar 07Buy143.671,760252,858170,666Mar 07 03:19 PM
WALSH MATTHEW MEVP, Chief Financial OfficerNov 16Buy157.001,000157,00026,416Nov 19 07:22 PM
COUGHLIN CHRISTOPHER JDirectorSep 06Buy190.6410,0001,906,39416,431Sep 07 08:31 AM
Boccuzi Joseph HDirectorAug 30Buy190.59900171,5313,885Sep 04 05:06 PM
FREYMAN THOMAS CDirectorAug 30Buy190.691,100209,7592,658Sep 04 05:07 PM
Basgoz NesliDirectorAug 30Sale190.051,055200,5037,359Sep 04 05:08 PM
Basgoz NesliDirectorAug 10Option Exercise81.161,889153,3119,248Aug 14 05:32 PM
Meury WilliamEVP & Chief Commercial OfficerMay 17Option Exercise68.1121,2521,447,47440,154May 21 05:21 PM
Meury WilliamEVP & Chief Commercial OfficerMay 17Sale154.5924,4253,775,86115,729May 21 05:21 PM